|本期目录/Table of Contents|

[1]董贺楠,王景雨,王猛,等.膀胱癌患者经尿道电切术后合并尿道感染病原菌分布及药物敏感性分析[J].天津医科大学学报,2024,30(04):323-327.[doi:10.20135/j.issn.1006-8147.2024.04.0323]
 DONG Henan,WANG Jingyu,WANG Meng,et al.Distribution of isolated pathogenic bacteria and drug sensitivity analysis of bladder cancer patients complicated with urethral infection after transurethral resection[J].Journal of Tianjin Medical University,2024,30(04):323-327.[doi:10.20135/j.issn.1006-8147.2024.04.0323]
点击复制

膀胱癌患者经尿道电切术后合并尿道感染病原菌分布及药物敏感性分析(PDF)
分享到:

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:
30卷
期数:
2024年04期
页码:
323-327
栏目:
肿瘤疾病专题
出版日期:
2024-07-10

文章信息/Info

Title:
Distribution of isolated pathogenic bacteria and drug sensitivity analysis of bladder cancer patients complicated with urethral infection after transurethral resection
文章编号:
1006-8147(2024)044-0323-05
作者:
董贺楠1王景雨2王猛2赵洁2周春雷2穆红2崔川跃3冯玉庆4彭林2
(1.天津医科大学一中心临床学院,天津300192;2.天津市第一中心医院检验科,天津300192;3.佳木斯医科大学临床学院,佳木斯154007;4.天津市第一中心医院病理科,天津300192)
Author(s):
DONG Henan1WANG Jingyu2WANG Meng2ZHAO Jie2ZHOU Chunlei2MU Hong2CUI Chuanyue3FENG Yuqing4PENG Lin2
(1.The First Central Clinical School,Tianjin Medical University,Tianjin 300192,China; 2.Department of Clinical Laboratory,Tianjin First Central Hospital,Tianjin 300192,China;3.Clinical College of Jiamusi Medical University,Jiamusi 154007,China;4.Department of Pathology,Tianjin First Central Hospital,Tianjin 300192,China)
关键词:
膀胱癌尿道感染病原菌耐药性泌尿系统
Keywords:
bladder cancer urinary tract infection pathogenic bacteria drug resistance urinary system
分类号:
R446. 5
DOI:
10.20135/j.issn.1006-8147.2024.04.0323
文献标志码:
A
摘要:
目的:分析膀胱癌(BCa)患者经尿道电切术后合并尿道感染(UTI)病原菌分布特征及药敏特点。方法:回顾性分析2021年7月—2023年8月天津市第一中心医院泌尿外科经尿道电切术后合并UTI的BCa患者尿液中病原菌的种类分布和药物敏感性数据。结果:共分离培养出164株病原菌,其中革兰阴性(G-)杆菌78株(47.6%),以大肠埃希菌、肺炎克雷伯菌、阴沟肠杆菌为主;革兰阳性(G+)球菌76株(46.3%),主要为凝固酶阴性葡萄球菌属(CoNS)和肠球菌属;真菌10株(6.1%),主要以念珠菌属为主。G-杆菌中大肠埃希菌对左氧氟沙星耐药率高达83.87%;肺炎克雷伯菌对头孢曲松的耐药率高达66.67%;阴沟肠杆菌对头孢西丁、阿莫西林耐药率高达100%。G+球菌中表皮葡萄球菌对青霉素(95%)、红霉素(80%)耐药率较高;粪肠球菌对红霉素耐药率高达68.42%;屎肠球菌对红霉素、青霉素、左氧氟沙星耐药率均为100%。本研究未检测到耐药真菌。结论:尿道电切术后合并UTI尿液中分离病原菌以G-杆菌和G+球菌为主。分离病原菌对抗菌药物的敏感性有较明显差异。
Abstract:
Objective: To analyze the clinical pathogenic bacteria distribution and drug sensitivity characteristics of bladder cancer (BCa) patients complicated with urinary tract infection(UTI) after transurethral resection. Methods: The species distribution and drug sensitivity data of pathogens in urine of BCa patients with UTI after transurethral resection in the Department of Urology,Tianjin First Central Hospital from July 2021 to August 2023 were retrospectively analyzed. Results: A total of 164 pathogenic bacteria were isolated and cultured,of which 78(47.6%) were Gram-negative(G-) bacilli,mainly Escherichia coli,Klebsiella pneumoniae and Enterobacter cloformis. There were 76 cases(46.3%) of Gram-positive(G+) micrococcus,mainly coagulase negative Staphylococcus(CoNS) and Enterococcus. There were 10 cases(6.1%) of fungi,mainly Candida. The resistance rate of Escherichia coli to levofloxacin was 83.87%. The resistance rate of Klebsiella pneumoniae to ceftriaxone was 66.67%. The resistance rate of enterobacter cloacae to cefoxitin and amoxicillin was up to 100%. Staphylococcus epidermidis had a higher resistance rate to penicillin(95%) and erythromycin(80%) in G+ cocci. The resistance rate of enterococcus faecalis to erythromycin was 68.42%. The resistance rate of Enterococcus faecium to erythromycin,penicillin and levofloxacin was 100%. No drug-resistant fungi were detected in this study. Conclusion: The main pathogens isolated in urine of BCa patients with UTI after transurethral resection are G- Bacillus and G+ coccus. The sensitivity of isolated pathogens to antimicrobial agents is significantly different.

参考文献/References:

[1] SIEGEL R L,MILLER K D,FUCHS H E,et al. Cancer Statistics,2022[J]. CA Cancer J Clin,2022,72(1):7-33.
[2] FERLAY J,COLOMBET M,SOERJOMATARAM I,et al. Cancer sta-tistics for the year 2020: an overview[J]. Int J Cancer,2021,149(4):778-789.
[3] SAGINALA K,BARSOUK A,ALURU J S,et al. Epidemiology of Bladder Cancer[J]. Med Sci (Basel),2020,8(1):15.
[4] HUANG Q,ZI H,LUO L,et al. Secular trends of morbidity and mortality of prostate,bladder,and kidney cancers in China,1990 to 2019 and their predictions to 2030[J]. BMC Cancer,2022,22(1):1164.
[5] DING X F,LUAN Y,LU S M,et al. Risk factors for infection complications after transrectal ultrasound-guided transperineal prostate biopsy[J]. World J Urol,2021,39(7):2463-2467.
[6] FRIEDRICH V,CHOI H W. The urinary microbiome: role in bladder cancer and treatment[J]. Diagnostics (Basel),2022,12(9):2068.
[7] 中华人民共和国卫生部. 医院感染诊断标准(试行)[J]. 中华医学杂志,2001,81(5):61-67.
[8] MILLS J T,RAPP D E,SHAW N M,et al. Effect of active versus passive void trials on time to patient discharge,urinary tract infection,and urinary retention: a randomized clinical trial[J]. World J Urol,2020,38(9):2247-2252.
[9] 王天威,杨荣,刘天遥,等. 机器人辅助腹腔镜下根治性全膀胱切除术后并发症及其危险因素分析[J]. 中华腔镜泌尿外科杂志(电子版),2020,14(1):8-11.
[10] FERREIRA M P,COGHILL A E,CHAVES C B,et al. Outcomes of cervical cancer among HIV-infected and HIV-uninfected women treated at the Brazilian National Institute of Cancer[J]. Aids,2017, 31(4):523-531.
[11] 王晓寒,杜鹏飞,屈晓东,等. 非肌层浸润性膀胱癌患者TURBT术后并发尿路感染危险因素及预测模型构建[J]. 中华医院感染学杂志,2023,33(7):1071-1075.
[12] 王哲,张敬,张潮,等. 经尿道膀胱肿瘤切除术后尿道感染病原菌及预测模型[J]. 中华医院感染学杂志,2023,33(19):2944-2948.
[13] TALLOSY S P,POLES M Z,RUTAI A,et al. The microbial composition of the initial insult can predict the prognosis of experimental sepsis[J]. Sci Rep,2021,11(1):22772.
[14] 王景雨,周春雷,王猛,等. 尿道致病性大肠杆菌毒力因子与其抗生素耐药性之间的关系[J]. 天津医科大学学报,2022,28(6):648-653.
[15] 冯丽娜,李从荣,杨勇文,等. 肠杆菌科细菌产碳青霉烯酶基因型研究[J]. 中华实验和临床感染病杂志(电子版),2018,12(4):334-340.
[16] 冯四洲,陈欣. 血液病患者多药耐药革兰氏阴性菌感染的经验性治疗策略[J]. 临床血液学杂志,2019,32(3):170-173.
[17] 胡付品,郭燕,朱德妹,等. 2021年CHINET中国细菌耐药监测[J]. 中国感染与化疗杂志,2022,22(5):521-530.
[18] 谢晓娟,兰天,高晶. 医院感染患者凝固酶阴性葡萄球菌的药敏试验以及耐药基因研究[J]. 广东医学,2023,44(10):1254-1257.
[19] 胡付品,郭燕,朱德妹,等. 2018年CHINET中国细菌耐药性监测[J]. 中国感染与化疗杂志,2020,20(1):1-10.
[20] 全国细菌耐药监测网. 全国细菌耐药监测网2014—2019年细菌耐药性监测报告[J]. 中国感染控制杂志,2021,20(1):15-31.
[21] MCCARTY T P,LUETHY P M,BADDLEY J W,et al. Clinical utility of antifungal susceptibility testing[J]. JAC Antimicrob Resist,2022,4(3):dlac067.
[22] 赵董强,王彦,杨雪芹,等. 2015—2019年连云港市第二人民医院感染真菌患者菌株分布及耐药性分析[J]. 现代药物与临床,2021,36(8):1723-1727.
[23] 潘小虹,郭亮生,刘利芬,等. 外阴阴道念珠菌病患者感染致病真菌的分布特点及基因型分析[J]. 中国病原生物学杂志,2022, 17(3):321-324.
[24] 马庆林,朱岩,胡艺琳,等. 2018—2022年深圳市妇幼保健院分离真菌的分布及耐药情况分析[J]. 现代药物与临床,2023,38(8):2051-2055.

相似文献/References:

[1]陈可新,郝晓东,薄志强,等.≤pT2N0M0膀胱癌根治术后近期复发的影响因素分析[J].天津医科大学学报,2017,23(04):357.
 CHEN Ke-xin,HAO Xiao-dong,BO Zhi-qiang,et al.Influencing factors and prognosis of short-term relapse after radical cystectomy of primary bladder cancer(≤pT2N0M0)[J].Journal of Tianjin Medical University,2017,23(04):357.
[2]孟旭英,李珍瑾,郭剑超.组蛋白甲基转移酶EZH2抑制剂联合抗癌药物对膀胱癌细胞功能影响的研究[J].天津医科大学学报,2018,24(01):25.
 MENG Xu-ying,LI Zhen-jin,GUO Jian-chao.Effect of histone methyltransferase EZH2 inhibitor combined with anticancer drugs on migration and proliferation of bladder cancer cells[J].Journal of Tianjin Medical University,2018,24(04):25.
[3]刘 莉 康家旗 综 述,刘晓强 审 校.膀胱癌外周血生物标志物研究进展[J].天津医科大学学报,2018,24(06):566.
[4]刘志飞,张志宏,邢力永,等.RRM1 mRNA与吉西他滨药物膀胱灌注治疗膀胱癌疗效的关系[J].天津医科大学学报,2019,25(01):51.
 LIU Zhi-fei,ZHANG Zhi-hong,XING Li-yong,et al.The relationship between expression of RRM1 mRNA and efficacy of intravesical of gemcitabine in patients with nonmuscle-insive bladder caner[J].Journal of Tianjin Medical University,2019,25(04):51.
[5]付真睿,盛 飞,张昌文,等.SOX6在膀胱癌发生发展中的作用及相关机制[J].天津医科大学学报,2019,25(04):373.
 FU Zhen-rui,SHENG Fei,ZHANG Chang-wen,et al.The characteristics of SOX6 in development of bladder cancer and relevant mechanism[J].Journal of Tianjin Medical University,2019,25(04):373.
[6]王银蕾,杨 瀚,高 杰,等.PITX2启动子甲基化及其与膀胱癌临床病理的关系[J].天津医科大学学报,2020,26(01):39.
 WANG Yin-lei,YANG Han,GAO Jie,et al.Methylation of PITX2 promoter and relationship with clinical pathology of bladder cancer[J].Journal of Tianjin Medical University,2020,26(04):39.
[7]王玉杰,沈冲,高深,等.长链非编码RNA-FENDRR在膀胱癌组织中的表达及临床意义[J].天津医科大学学报,2020,26(05):445.
 WANG Yu-jie,SHEN Chong,GAO Shen,et al.Expression of long non-coding RNA FENDRR in human bladder cancer tissues and Clinical significance[J].Journal of Tianjin Medical University,2020,26(04):445.
[8]朱建强,郑志文,付青峰,等.人工纳米材料在膀胱癌诊疗中的研究进展[J].天津医科大学学报,2022,28(05):563.
[9]陆益,于佳熙,梁政.氯丙嗪对膀胱癌BT-B细胞迁移功能的影响[J].天津医科大学学报,2022,28(06):621.
 LU Yi,YU Jia-xi,LIANG Zheng.The effect of chlorpromazine on the migration of BT-B cellsin bladder cancer[J].Journal of Tianjin Medical University,2022,28(04):621.
[10]王景雨,周春雷,王猛,等.尿道致病性大肠杆菌毒力因子与其抗生素耐药性之间的关系[J].天津医科大学学报,2022,28(06):648.
 WANG Jing-yu,ZHOU Chun-lei,WANG Meng,et al.Relationship between virulence factors of urethral pathogenic Escherichia coli(UPEC) and antibiotic resistance[J].Journal of Tianjin Medical University,2022,28(04):648.

备注/Memo

备注/Memo:
基金项目:天津市卫健委科技项目(TJWJ2021QN016);天津市医学重点学科建设项目(2021);天津市第一中心医院青年新锐项目(2022)
作者简介:董贺楠(1997-),男,硕士在读,研究方向:泌尿系统感染;
通信作者:彭林,E-mail: lpengfch@yahoo.com。
更新日期/Last Update: 2024-07-10